0001179110-21-000182.txt : 20210105 0001179110-21-000182.hdr.sgml : 20210105 20210105165713 ACCESSION NUMBER: 0001179110-21-000182 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Hongming CENTRAL INDEX KEY: 0001710697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 21506709 MAIL ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 edgar.xml FORM 4 - X0306 4 2021-01-04 0 0001479419 Kala Pharmaceuticals, Inc. KALA 0001710697 Chen Hongming C/O KALA PHARMACEUTICALS, INC. 490 ARSENAL WAY, SUITE 210 WATERTOWN MA 02472 0 1 0 0 Chief Scientific Officer Common Stock 2021-01-04 4 A 0 22666 0 A 186515 D Stock Option (right to buy) 6.86 2021-01-04 4 A 0 90667 0 A 2031-01-03 Common Stock 90667 90667 D Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with Issuer, the RSUs will vest as to 1/3 of the shares underlying the RSUs on January 4, 2022, as to 1/3 of the shares underlying the RSUs on January 4, 2023 and as to the final 1/3 of shares underlying the RSUs on January 4, 2024. Includes 99,666 unvested RSUs. This option was granted on January 4, 2021 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter. /s/ Eric Trachtenberg, Attorney-in-Fact 2021-01-05